Delivery Order SPE2DR25D1053-SPE2DR26FT645
- Not listed
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on April 24, 2025, by the Defense Logistics Agency to supply Eliquis 5 mg tablets (60-count packages) with a ceiling value of $38,436.76. This firm fixed-price delivery order, which has an ultimate completion date of April 25, 2025, represents a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $33,649.89 by the Defense Logistics Agency (DLA) on September 5, 2025. The contract calls for the supply of Eliquis 5 mg tablets in quantities of 60 units, with a firm fixed price structure and an ultimate completion date of September 8, 2025. This is a competitively awarded, non-set-aside contract that will be fulfilled at the vendor's Conshohocken,...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order valued at $12,049.99 by the Defense Logistics Agency (DLA) for the supply of Eliquis 5 mg tablets (60-count packages). This competitively awarded, firm fixed-price delivery order carries an ultimate completion date of August 26, 2025. The award was issued on August 25, 2025, with no set-aside designation applied. This delivery order is a child contract executed under AmerisourceBergen's...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $12,131.67 on October 24, 2025, by the Defense Logistics Agency (DLA) for the supply of Eliquis 5 mg tablets (60-count packages). This firm fixed-price, non-set-aside contract is scheduled for completion by October 27, 2025, with the place of performance at AmerisourceBergen's corporate office in Conshohocken. The delivery order was issued under...
- AmerisourceBergen Drug Corp was awarded a delivery order on September 9, 2025, by the Defense Logistics Agency to supply 60 tablets of Eliquis 5 mg for $12,352.75, with final delivery required by September 10, 2025. This competitively awarded, firm fixed-price delivery order represents a continuation of the vendor's substantial pharmaceutical supply relationship with the federal government. The order was fulfilled from AmerisourceBergen's location in Conshohocken, Pennsylvania, where the company...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $10,157.96 by the Defense Logistics Agency (DLA) on July 28, 2025, with an ultimate completion date of July 29, 2025. The award is for the supply of Eliquis 5 mg tablets in a 60-count quantity, representing a firm fixed price, competitively awarded delivery order with no set-aside designation. This contract award is executed as a child order under...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on November 4, 2025, by the Defense Logistics Agency (DLA) for the supply of Eliquis 5 mg tablets (60-count packages). This competitively awarded, firm fixed-price delivery order carries a ceiling value of $17,847.15 and is scheduled for completion by November 5, 2025. The award represents fulfillment under AmerisourceBergen's broader Indefinite Delivery...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on October 28, 2025, for the supply of Eliquis 5 mg tablets (60-count packaging) with a ceiling value of $11,515.58. This competitively awarded, firm fixed-price delivery order is funded by the Defense Logistics Agency and is scheduled for completion by October 29, 2025. The contract carries no set-aside designation, reflecting the open competition process...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on September 22, 2025, by the Defense Logistics Agency (DLA) for the supply of Eliquis 5 mg tablets (60-count packages) with a ceiling value of $32,285.78. This firm fixed-price delivery order, with an ultimate completion date of September 23, 2025, was competitively awarded without set-aside designation and represents performance at the contractor's corporate...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency for 60 tablets of Eliquis 2.5 mg with a contract ceiling value of $1,965.60. The award, issued on August 20, 2025, utilizes firm fixed price pricing and is scheduled for completion by August 21, 2025. This is a non-set-aside, competitively awarded contract that represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with...
- SPE2DR25D1053Indefinite Delivery Contract
- SPE2DR25D1053-SPE2DR26FT645Delivery Order
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $43,474.14 by the Defense Logistics Agency on November 5, 2025, for the supply of Eliquis 5 mg tablets (60-count packages). This firm fixed-price, non-set-aside contract is scheduled for completion by November 6, 2025, and will be performed at the contractor's Conshohocken facility. The award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), which is valued at $999,999,999.00 and extends through December 2026. This delivery order supports the Defense Health Agency's pharmaceutical supply chain, enabling the distribution of critical medications to military healthcare systems and veterans' facilities. AmerisourceBergen's established position as a federal pharmaceutical vendor reflects its competitive capability to fulfill federal medical procurement requirements across a broad spectrum of therapeutic domains. The Eliquis delivery aligns with the company's extensive portfolio of brand-name and generic medications supplied through the DLA Medical Supply Chain network.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $43.5k | 11/5/25 |